“Janssen Accused of Withholding Data on Risperdal Side Effect in Autism”

11
MedPageToday reports that Janssen Pharmaceuticals omitted data from a 2003 study that connected Risperdal with serious side effects. Janssen was previously sued by the FDA for marketing Risperdal for off-label uses and settled for $2.2 billion in 2013. Earlier this year, a man with autism was awarded $2.5 million after growing breasts while on Risperdal. According to MedPage, documents from this latest case reveal missing data tables from a 2003 study “designed to ferret out potential adverse effects of long-term risperidone use.” The missing tables were related to elevated prolactin levels and side effects, including gynecomastia in men.

“Pass on the Pill or Pass Out” Campaign Warns Women About Addyi

0
“The National Women’s Health Network launched the 'Pass on the Pink Pill – Or Pass Out' campaign, to warn women of the marginal benefits...

Scientists Clarify Risks of Augmenting with Antipsychotic Medications for Depression

25
The researchers found that while antipsychotic drugs may be slightly more effective than alternative antidepressants, they come with a much higher side effect burden.

Veterans with both PTSD and Dementia More Likely to be Prescribed Antipsychotics

2
Researchers found that veterans with both conditions had higher odds of being prescribed second-generation antipsychotics than those presenting with just PTSD.

Expert Urges Doctors to Stop Prescribing Seroquel for Insomnia

4
From National Post: Many physicians are prescribing a low dose of Seroquel, an atypical antipsychotic, to patients with insomnia. Experts warn that even a low...

“Protect California Foster Youth from Dangerous Psychiatric Drugs”

0
The Santa Cruz Sentinel reports on legislation being passed in California to go after physicians who overprescribe psychiatric drugs to foster youth. The proposed legislation also targets government agencies that fail to offer nondrug alternative therapies to help foster youth recover from traumatic childhoods.

Non-Pharmacological Interventions More Effective For Health in Schizophrenia

24
Review compares the effectiveness of pharmacological and non-pharmacological interventions for improving physical health outcomes in people diagnosed with schizophrenia.

$8 Million Awarded to Family Of Man Who Died in Risperdal Trial

4
A California jury ruled that Johnson & Johnson’s Janssen Pharmaceutical and a psychiatrist were responsible for the death of 25-year-old Leo Liu. During a clinical trial for Risperdal, Liu died of a heart injury that was “further complicated” by the drug and ignored by the study doctors. Janssen was found 70% responsible for Liu’s death and ordered to pay $5.6 million to the family.

We Need to Talk About Frankie

0
In this piece for The Cut, Dyan Neary details the story of Frankie Perry, a man whose life was forever altered by being prescribed an...

“FDA Forced to Release Adverse Event Reports on Psychiatric Drugs”

0
Following a lawsuit brought by Andrew Thibault of Parents Against Pharmaceutical Abuse (PAPA), the FDA has produced adverse event and severe adverse event reports...

“Punish People, Not Just Corporations”

3
Drug makers have faced large fines for unethical and harmful practices but have simply treated these as a cost of doing business. Ed Silverman reports...

Study Reduces Over-prescription of Antipsychotics in Older Adults

8
New intervention shows promise in reducing over-prescription of off-label antipsychotics in older adults.

Antidepressants and the Problem of Withdrawal

0
In this episode of WBUR's On Point Radio, Benedict Carey, author of the recent New York Times report on antidepressant withdrawal, discusses the topic of discontinuing...

Missouri Sued for Over-Drugging Foster Children

4
From Reuters: Two youth legal advocacy groups have filed a lawsuit against Missouri for over-exposing foster children to psychotropic drugs. The lawsuit seeks a court...

The Recovery After an Initial Schizophrenia Episode (RAISE) Study: Notes from the Trenches

43
I was a psychiatrist who participated in the Recovery After an Initial Schizophrenia Episode Early Treatment Program (RAISE ETP). Although I welcomed the positive headlines that heralded the study's results, the reports left me with mixed feelings. What happened to render the notion that talking to people about their experiences and helping them find jobs or go back to school is something novel?

Type 2 Diabetes and Antidepressant Use: Is There a Causal Link?

0
From EndocrinologyAdvisor: A recent meta-analysis suggests that antidepressant drug use may increase patients' risk of diabetes. According to the lead investigator, over 1 million diabetes...

A Mental Patient’s View of the Body

7
In 20 years of inpatient hospitalization, the psychiatrists that I encountered focused almost exclusively on treating my diseased mind and had no concept or interest in the body. While the wheels of “progress” turn slowly in mental health, I hope that along with ongoing advocacy there will be a focus on responsible health counseling and supporting people in healthier eating and living.
binge eating

Is Binge Eating Disorder Just Another Made-Up Disease?

108
If a person binges habitually, upon sensing certain stimuli the pancreas prepares the body with insulin, and simultaneously, the stomach prepares by getting more acidic. This means that for many of us, the drive to binge is a physical need. Therapy blames the patient for “bad coping” when all she is doing is responding to her body's signals.

In Chronic Patients, Antipsychotics Have Limited Efficacy in Reducing Symptoms

6
A large review and meta-analysis of 167 studies across 60 years dissects placebo-controlled randomized controlled trials of antipsychotic drugs.

Low Prevalence of Obesity and Metabolic Syndrome in Never-Treated Chronic Schizophrenia

0
Research from India indicates that "schizophrenia in the absence of antipsychotic drug treatment is not a factor contributing to high prevalence of metabolic abnormalities." Abstract...

No Metabolic Risk for Antipsychotic-Naive Patients

0
An Austrian study of the baseline prevalence of metabolic abnormalities and changes following treatment with five commonly-used antipsychotic drugs (haloperidol, amisulpride, olanzapine, quetiapine or...

Many Foster Kids Are Still Being Prescribed Antipsychotic Drugs

2
Many experts expressed concern when the rate of antipsychotic prescriptions to children in foster care showed a rapid increase, peaking in 2008, and new recommendations and policies have tried to curb the use of these drugs. While the rate has plateaued, a new study points out that the “new normal” prescription levels are still dangerously high. The data reveals that almost one in ten children in foster care are currently being prescribed antipsychotic drugs with dangerous side-effects, many for diagnoses like ‘ADHD’ and disruptive behavior.

Researchers Probe Connections Between Physical Activity and ‘Severe Mental Illness’

13
How does physical activity affect people diagnosed with bipolar, schizophrenia and major depressive disorders?

ADHD Medication Slows Growth, Increases Obesity

0
Treating attention deficit/hyperactivity disorder (ADHD) with stimulants affects growth and is likely to cause a higher BMI in later adolescence, according to research from...

In Praise of Defiance

0
From Aeon: Throughout history, psychiatry has pathologized defiance and continues to label individuals who resist authority and stand up for their rights as mentally ill....